Covaxin Meets WHO Criteria For Delta, Shows Lancet Study: Bharat Biotech

Hyderabad-based Bharat Biotech has said that the results compare well with 65.2 per cent efficacy against Delta variant obtained during controlled phase 3 clinical trials of COVAXIN conducted among...

source https://www.ndtv.com/india-news/covaxin-meets-who-criteria-for-delta-shows-lancet-study-bharat-biotech-2623817